About a-team Marketing Services
The knowledge platform for the financial technology industry
The knowledge platform for the financial technology industry

A-Team Insight Briefs

RegGenome Launches GenAI-Optimised Reg-Data Repository

Subscribe to our newsletter

RegGenome, a spin-out from the University of Cambridge, has launched an enriched regulatory data repository powered by Generative Artificial Intelligence (GenAI). This solution aims to address the increasing regulatory costs and complexities faced by firms by leveraging advanced AI technologies for regulatory operations and compliance management.

A study by Accenture indicates that while 93% of compliance leaders see AI as a simplifier of compliance processes, 90% anticipate a 30% increase in compliance costs over the next two years due to traditional, labor-intensive approaches. RegGenome’s new service provides a jurisdiction-agnostic repository of rich, descriptive, and inferential metadata optimized for GenAI algorithms, facilitating the identification, interrogation, presentation, and management of regulations.

“Our GenAI-optimised data is vital for any firm investing in modernising its data infrastructure and adopting AI. As a data-only provider, we can facilitate the creation of a central regulatory data set that can feed multiple internal use cases. By adopting our data, organisations are well-positioned to leverage the transformative potential of AI,” said Chief Operating Officer Mark Johnston.

RegGenome uses a universal information structure to organize and standardize regulations, operationalizing documentation from any authority in any language. This structure is built on provenance and regulatory standards reviewed by experts at the University of Cambridge, ensuring data integrity, reliability, and relevance. The GenAI-optimized data supports the development of standards-based solutions that enhance the capabilities of foundational large language models (LLMs), enabling reliable management of regulatory changes, policy impact assessments, information retrieval, query responses, and document summarization.

“With flexible delivery methods, our data integrates into any existing application or tool, maintaining continuity with current business operations. We meet you where you are, and that is the type of freedom customers get from a pure data-only provider,” added Head of Product Jonny Scurr.

RegGenome’s data empowers organizations to conduct granular searches, receive timely updates via custom alerts, identify common regulatory obligations across jurisdictions, and efficiently route relevant regulations to appropriate teams. This foundational dataset promises to enhance existing systems and prepares organizations for the evolving regulatory environment.

Subscribe to our newsletter

Related content

WEBINAR

Recorded Webinar: GenAI and LLM case studies for Surveillance, Screening and Scanning

As Generative AI (GenAI) and Large Language Models (LLMs) move from pilot to production, compliance, surveillance, and screening functions are seeing tangible results – and new risks. From trade surveillance to adverse media screening to policy and regulatory scanning, GenAI and LLMs promise to tackle complexity and volume at a scale never seen before. But...

BLOG

UK Equity Consolidated Tape and EU MiFIR – Two Data Regimes, One Control Problem

The UK’s proposed equity consolidated tape is framed as a response to long-standing fragmentation in equity market data. By aggregating post-trade information and an attributed best bid and offer across trading venues, the tape is intended to provide a single, standardised view of UK equity trading. At the same time, transaction reporting under the Markets...

EVENT

RegTech Summit New York

Now in its 9th year, the RegTech Summit in New York will bring together the RegTech ecosystem to explore how the North American capital markets financial industry can leverage technology to drive innovation, cut costs and support regulatory change.

GUIDE

What the Global Legal Entity Identifier (LEI) Will Mean for Your Firm

It’s hard to believe that as early as the 2009 Group of 20 summit in Pittsburgh the industry had recognised the need for greater transparency as part of a wider package of reforms aimed at mitigating the systemic risk posed by the OTC derivatives market. That realisation ultimately led to the Dodd Frank Act, and...